Sympazan FDA Approval History
FDA Approved: Yes (First approved November 1, 2018)
Brand name: Sympazan
Generic name: clobazam
Dosage form: Oral Film
Company: Aquestive Therapeutics, Inc.
Treatment for: Lennox-Gastaut Syndrome
Sympazan (clobazam) is an oral film benzodiazepine formulation indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome.
Development timeline for Sympazan
|Nov 1, 2018||Approval FDA Approves Sympazan (clobazam) Oral Film for Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.